2008-November Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Sun Nov 2 08:33:09 2008
Ending: Sun Nov 30 22:58:54 2008
Messages: 100

• [Ip-health] The Medical Innovation Prize Fund (S.2210, 110th Congress) and the WTO TRIPS Agreement   James Love
• [Ip-health] Re: [e-drug] MSF Briefing document on Kenya's 2008 Anti-Counterfeit Bill   Vijay Thawani
• [Ip-health] Update on the Novartis case in India - 3 November 2008   aidslaw@lawyerscollective.org
• [Ip-health] X PRIZE Foundation to Help Fight Tuberculosis Worldwide with Gates Foundation Support   James Love
• [Ip-health] Patent versus Patients Conference at Loyola Chicago   Cynthia Ho
• [Ip-health] INVITATION- Lunch Debate" How much does the European Commission pay for Turberculosis R&D?" MSF report Launch- European Parliament Nov 12th.   Alexandra HEUMBER
• [Ip-health] The George Institute seeks Head of Reseach, Health Policy Division   Elisabeth Quinnell
• [Ip-health] The election of Barack Obama as President of the United States   James Love
• [Ip-health] Draft Res. Hum Rts and Access to Meds   Sean Flynn
• [Ip-health] INVITATION- "How much does the EC pay for tubercolosis R&D- MSF launch report- European Parliament Nov 12th, 12:30-2pm   Alexandra HEUMBER
• [Ip-health] IP Quarterly Update - WHO Anti-coutnerfeiting Taskforce   munoz@southcentre.org
• [Ip-health] Re: [A2k] The election of Barack Obama as President of the United States   Jeffrey A. Williams
• [Ip-health] The IP challenges facing Barack Obama   Riaz K Tayob
• [Ip-health] MSF comments on AMFm proposal   Tido.von.SCHOENANGERER@geneva.msf.org
• [Ip-health] LAST DAY TO REGISTER Re: INVITATION- Lunch Debate" How much does the European Commission pay for Turberculosis R&D?" MSF's report Launch- European Parliament Nov 12th.   Alexandra HEUMBER
• [Ip-health] MMV MoH Uganda report reveals ACTs urgently need to be made more affordable   Jaya Banerji
• [Ip-health] Selection Patents Upheld by Supreme Court of Canada   Jeremy de Beer
• [Ip-health] UAEM Calls On Indian Government To Reconsider Legislation Regarding The Patenting Of Publicly-Funded Research   Anjali Dalal
• [Ip-health] UAEM Calls On Indian Government To Reconsider Legislation Regarding The Patenting Of Publicly-Funded Research   Ethan Guillen
• [Ip-health] REMINDER: KEI brownbag lunch on US Priority Review Voucher, Thursday, November 13   Malini Aisola
• [Ip-health] Public Hearing Isolates Brazil Patent Office President and Demonstrates Harmony among Ministers   =?ISO-8859-1?Q?Gabriela=20Chaves?=
• [Ip-health] Vacancy: US Manager, =?UTF-8?B?4oCcQWNjZXNzIHRvIEVzc2VudGlhbCBNZWRpY2luZXMgQ2FtcGFpZ27igJ0=?= =?UTF-8?B?IERvY3RvcnMgV2l0aG91dCBCb3JkZXJzL01TRi1VU0E=?=   Buddhima Lokuge
• [Ip-health] Goozner: Coartem and the FDA Priority Review Voucher   robert weissman
• [Ip-health] REMINDER: MSF's Launch Report- COUGH UP FOR TB- European Parliament Nov 12th. Lunch Debate" How much does the European Commission pay for Turberculosis R&D?"   Alexandra HEUMBER
• [Ip-health] African NGO Forum Passes Resolution on the Right to Access to Needed Medicines   Mike Palmedo
• [Ip-health] Impact Of The Probable Incorporation Of An Additional Step (Of Public Interest) In Indian Injunction Jurisprudence   Judit Rius Sanjuan
• [Ip-health] MSF report "Cough up for TB" and Press Release of the underfunding for research for TB and other Neglected Diseases by the EC   Thiru Balasubramaniam
• [Ip-health] the Plumb book   James Love
• [Ip-health] TOMORROW: KEI brownbag lunch on US Priority Review Voucher   Malini Aisola
• [Ip-health] Making Medicines Accessible for All: The Health Impact Fund   Wenar, Leif
• [Ip-health] Global Health and Social Innovation Conference at Yale   Jennifer Staple
• [Ip-health] Which Country Spends The Most On Meds?   Judit Rius Sanjuan
• [Ip-health] Biotech Transfer Week Article: "As India Mulls Bill Modeled on Bayh-Dole,Critics Claim It May Stifle Innovation"   Ethan Guillen
• [Ip-health] New Oxfam report on R+D   Rohit Malpani
• [Ip-health] Do medication top-up fees mean the end of the NHS?   Joana Ramos
• [Ip-health] WHO discloses Expert Working Group on R&D financing   Thiru Balasubramaniam
• [Ip-health] New Oxfam paper: "Ending the R&D crisis in n Public Health : Promoting Pro-Poor Medical Innovation "   Isabel Mazzei
• [Ip-health] KEI reaction to WHO expert group names   James Love
• [Ip-health] FTC to investigate intellectual property & innovation (Public Hearing)   Manon Ress
• [Ip-health] The Health Impact Fund [date corrected]   Wenar, Leif
• [Ip-health] Concern about Keynote Speaker at Australian Medicines Policy Conference on Nov. 25   Joana Ramos
• [Ip-health] TWN INFO: Customs Organisation meeting ends in some disarray   Sangeeta
• [Ip-health] TWN INFO: NGOs criticize Customs Organisation's TRIPS-Plus initiative   Sangeeta
• [Ip-health] The Health Impact Fund and product monopolies   James Love
• [Ip-health] UNAIDS letter   Vanessa Wu
• [Ip-health] Re: The Health Impact Fund - a response to Love   Aidan Hollis
• [Ip-health] Interpol Seizes > 16m Counterfeit HIV, M, TB Rx   Jay Purcell
• [Ip-health] European Voice Article: Five-fold increase in TB research needed   Alexandra HEUMBER
• [Ip-health] WP editorial on Colombia FTA   Kaytee Riek
• [Ip-health] FromBamako: WHO strategy on research for health   thiru@keionline.org
• [Ip-health] Excerpts from HIF: compulsory licensing   James Love
• [Ip-health] HIF on the Sanders prize fund bill   James Love
• [Ip-health] HIF on why voluntary licensing of patents is not required   James Love
• [Ip-health] First cir. upholds med data regulation   Sean Flynn
• [Ip-health] Excerpts from HIF: compulsory licensing   michael.davis@law.csuohio.edu
• [Ip-health] Chalerm aims for more compulsory licensing for essential drugs   Kannikar KIJTIWATCHAKUL
• [Ip-health] WP editorial on Colombia FTA   Aaron Boyle
• [Ip-health] Excerpts from HIF: compulsory licensing   Riaz K Tayob
• [Ip-health] INDIAN PHARMACEUTICALS   Charles Clift
• [Ip-health] Entrepreneurial Volunteering Abroad: High Impact Opportunities   Jennifer Staple
• [Ip-health] US FTC To Hold Roundtable On Follow-On Biologics   Judit Rius Sanjuan
• [Ip-health] more on the HIF - December 1st event at Georgetown University, 1-5 pm   Noah B. Novogrodsky
• [Ip-health] impact of the HIF on generic industry in developing countries   James Love
• [Ip-health] Re: impact of the HIF on generic industry in developing countries   Aidan Hollis
• [Ip-health] =?Windows-1252?Q?Update_on_the_Novartis_case_before_IPAB_=96_18_November_?= =?Windows-1252?Q?2008?=   aidslaw@lawyerscollective.org
• [Ip-health] Re: impact of the HIF on generic industry in developing countries   James Love
• [Ip-health] Waxman wins chair of House Energy and Commerce Committee   robert weissman
• [Ip-health] Waxman wins chair of House Energy and Commerce Committee   Dalindyebo Bafana Shabalala
• [Ip-health] New US Administration: Tom Daschle Secretary of Health and Human Services   Judit Rius Sanjuan
• [Ip-health] Indian SMEs concerned with WHO's definition on counterfeit   Sangeeta
• [Ip-health] Economic times on counterfeit, Indian co and NGOs   Sangeeta
• [Ip-health] Indian generic cos on ACTA, WHO (IMPACT), WCO (SECURE)   Sangeeta
• [Ip-health] NGOs Urge Govt. to boycott WHO's IMPACT meeting   Sangeeta
• [Ip-health] Jan 12-13 in WashDC: Patents, Copyrights and Knowledge Governance: The Next Four Years   James Love
• [Ip-health] Re: impact of the HIF on generic industry in developing countries   Aidan Hollis
• [Ip-health] New BVGH's Priority Review Voucher Website   Judit Rius Sanjuan
• [Ip-health] Re: impact of the HIF on generic industry in developing countries   michael.davis@law.csuohio.edu
• [Ip-health] Re: impact of the HIF on generic industry in developing countries   Jeffrey A. Williams
• [Ip-health] Human Rights Watch,UN: Action Needed Against Unproven HIV/AIDS Treatments   Riaz K Tayob
• [Ip-health] India - CPI sees bid to block export of generic drugs   Riaz K Tayob
• [Ip-health] Millions Spent On Never-Reviewed Drugs - FDA Says It's Trying To Squeeze Unapproved Drugs From Market   Riaz K Tayob
• [Ip-health] Re: impact of the HIF on generic industry in developing countries   James Love
• [Ip-health] New technologies gearing up to meet rising demand for vital malaria drugs   elspeth bartlet
• [Ip-health] CPI sees bid to block export of generic drugs   Sangeeta
• [Ip-health] Thomas Pogge comment on debate on HIF   James Love
• [Ip-health] HIF and economies of scale and scope   James Love
• [Ip-health] Health Impact Fund   B.Baker@neu.edu
• [Ip-health] Take Action to help Children Living with HIV   Thabo Sephuma
• [Ip-health] Developing countries unite on health research (report on Bamako)   Judit Rius Sanjuan
• [Ip-health] HIF and generic competition   robert weissman
• [Ip-health] HIF and generic competition   Outterson, Michael Kevin
• [Ip-health] Thursday: Pogge & Hollis launch global health initiative at KCL (update)   Wenar, Leif
• [Ip-health] Trade-off between access and incentives   James Love
• [Ip-health] US military flu virus collection parallels WHO virus system   Sangeeta
• [Ip-health] Europe Accuses Drug Makers of Padding Health Care Costs   Riaz K Tayob
• [Ip-health] The Evidence Gap,The Minimal Impact of a Big Hypertension Study   Riaz K Tayob
• [Ip-health] India to fight for more CLIMATE FUNDs + Patent Regime + Proposed India-EU FTA   Indian Society For Sustainable Agriculture
• [Ip-health] Don't pull the plug on the Therapeutics Initiative   Joana Ramos
• [Ip-health] Public has little presence in PharmaCare talks   Joana Ramos
• [Ip-health] EU Slams Big Pharma for Blocking Generics, Seeks Public Comment in Prep of Antitrust Charges...   Jay Purcell

Last message date: Sun Nov 30 22:58:54 2008
Archived on: Sun Nov 30 22:58:54 2008

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...